Efficacy and safety of interferon-free treatment in patients with chronic hepatitis C
Not Applicable
Recruiting
- Conditions
- chronic hepatitis C
- Registration Number
- JPRN-UMIN000037575
- Lead Sponsor
- Osaka university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients treated with contraindicated drug together with direct acting antivirals 2. Patients who were judged inadequate to participate by researchers.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response rates at 24weeks after the end of treatment
- Secondary Outcome Measures
Name Time Method factors contributing to sustained virological response appearance of RAS(resistant associated substitutions) occurrence of hepatocellular carcinoma factors associated with occurrence of hepatocellular carcinoma changes in liver fibrosis and liver function life prognosis